{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["CBD - cannabidiol", "SARS-CoV-2", "endocannabinoid system (ECS)", "essential oil (EO)", "formulations", "terpenes", "therapeutics"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35242142", "DateCompleted": {"Year": "2022", "Month": "03", "Day": "14"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "02", "Day": "15"}], "Language": ["eng"], "ELocationID": ["841459", "10.3389/fimmu.2022.841459"], "Journal": {"ISSN": "1664-3224", "JournalIssue": {"Volume": "13", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in immunology", "ISOAbbreviation": "Front Immunol"}, "ArticleTitle": "Cannabidiol and Terpene Formulation Reducing SARS-CoV-2 Infectivity Tackling a Therapeutic Strategy.", "Pagination": {"StartPage": "841459", "MedlinePgn": "841459"}, "Abstract": {"AbstractText": ["In late 2019, COVID-19 emerged in Wuhan, China. Currently, it is an ongoing global health threat stressing the need for therapeutic compounds. Linking the virus life cycle and its interaction with cell receptors and internal cellular machinery is key to developing therapies based on the control of infectivity and inflammation. In this framework, we evaluate the combination of cannabidiol (CBD), as an anti-inflammatory molecule, and terpenes, by their anti-microbiological properties, in reducing SARS-CoV-2 infectivity. Our group settled six formulations combining CBD and terpenes purified from <i>Cannabis sativa</i> L, <i>Origanum vulgare</i>, and <i>Thymus mastichina</i>. The formulations were analyzed by HPLC and GC-MS and evaluated for virucide and antiviral potential by <i>in vitro</i> studies in alveolar basal epithelial, colon, kidney, and keratinocyte human cell lines.", "We demonstrate the virucide effectiveness of CBD and terpene-based formulations. F2TC reduces the infectivity by 17%, 24%, and 99% for CaCo-2, HaCat, and A549, respectively, and F1TC by 43%, 37%, and 29% for Hek293T, HaCaT, and Caco-2, respectively. To the best of our knowledge, this is the first approach that tackles the combination of CBD with a specific group of terpenes against SARS-CoV-2 in different cell lines. The differential effectiveness of formulations according to the cell line can be relevant to understanding the pattern of virus infectivity and the host inflammation response, and lead to new therapeutic strategies."], "CopyrightInformation": "Copyright \u00a9 2022 Santos, Barata, Charmier, Lehmann, Rodrigues, Melosini, Pais, Sousa, Teixeira, Santos, Rocha, Baylina and Fernandes."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "R&D&Innovation Department, EXMceuticals Portugal Lda, Lisboa, Portugal."}, {"Identifier": [], "Affiliation": "Cooperativa de Forma\u00e7\u00e3o e Anima\u00e7\u00e3o Cultural - Centre for Interdisciplinary Development and Research on Environment, Applied Management and Space (COFAC-DREAMS)-Universidade Lus\u00f3fona, Lisboa, Portugal."}], "LastName": "Santos", "ForeName": "Susana", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "LABMI - Laborat\u00f3rio de Biotecnologia M\u00e9dica e Industrial, PORTIC - Porto Research, Technology and Innovation Center, Porto, Portugal."}, {"Identifier": [], "Affiliation": "Metabesity Deopartment, i3S - Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Porto, Portugal."}], "LastName": "Barata", "ForeName": "Pedro", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "R&D&Innovation Department, EXMceuticals Portugal Lda, Lisboa, Portugal."}, {"Identifier": [], "Affiliation": "Cooperativa de Forma\u00e7\u00e3o e Anima\u00e7\u00e3o Cultural - Centre for Interdisciplinary Development and Research on Environment, Applied Management and Space (COFAC-DREAMS)-Universidade Lus\u00f3fona, Lisboa, Portugal."}], "LastName": "Charmier", "ForeName": "Adilia", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "R&D&Innovation Department, EXMceuticals Portugal Lda, Lisboa, Portugal."}], "LastName": "Lehmann", "ForeName": "In\u00eas", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "R&D&Innovation Department, EXMceuticals Portugal Lda, Lisboa, Portugal."}], "LastName": "Rodrigues", "ForeName": "Suzilaine", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "R&D&Innovation Department, EXMceuticals Portugal Lda, Lisboa, Portugal."}], "LastName": "Melosini", "ForeName": "Matteo M", "Initials": "MM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "LABMI - Laborat\u00f3rio de Biotecnologia M\u00e9dica e Industrial, PORTIC - Porto Research, Technology and Innovation Center, Porto, Portugal."}, {"Identifier": [], "Affiliation": "Metabesity Deopartment, i3S - Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Porto, Portugal."}], "LastName": "Pais", "ForeName": "Patrick J", "Initials": "PJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "LABMI - Laborat\u00f3rio de Biotecnologia M\u00e9dica e Industrial, PORTIC - Porto Research, Technology and Innovation Center, Porto, Portugal."}, {"Identifier": [], "Affiliation": "Metabesity Deopartment, i3S - Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Porto, Portugal."}, {"Identifier": [], "Affiliation": "Escola Superior de Sa\u00fade, Instituto Polit\u00e9cnico do Porto, Porto, Portugal."}], "LastName": "Sousa", "ForeName": "Andr\u00e9 P", "Initials": "AP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "LABMI - Laborat\u00f3rio de Biotecnologia M\u00e9dica e Industrial, PORTIC - Porto Research, Technology and Innovation Center, Porto, Portugal."}, {"Identifier": [], "Affiliation": "Metabesity Deopartment, i3S - Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Porto, Portugal."}, {"Identifier": [], "Affiliation": "Escola Superior de Sa\u00fade, Instituto Polit\u00e9cnico do Porto, Porto, Portugal."}], "LastName": "Teixeira", "ForeName": "Catarina", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "LABMI - Laborat\u00f3rio de Biotecnologia M\u00e9dica e Industrial, PORTIC - Porto Research, Technology and Innovation Center, Porto, Portugal."}, {"Identifier": [], "Affiliation": "Metabesity Deopartment, i3S - Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Porto, Portugal."}, {"Identifier": [], "Affiliation": "Escola Superior de Sa\u00fade, Instituto Polit\u00e9cnico do Porto, Porto, Portugal."}], "LastName": "Santos", "ForeName": "In\u00eas", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "LABMI - Laborat\u00f3rio de Biotecnologia M\u00e9dica e Industrial, PORTIC - Porto Research, Technology and Innovation Center, Porto, Portugal."}, {"Identifier": [], "Affiliation": "Metabesity Deopartment, i3S - Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Porto, Portugal."}], "LastName": "Rocha", "ForeName": "Ana Catarina", "Initials": "AC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "LABMI - Laborat\u00f3rio de Biotecnologia M\u00e9dica e Industrial, PORTIC - Porto Research, Technology and Innovation Center, Porto, Portugal."}, {"Identifier": [], "Affiliation": "Metabesity Deopartment, i3S - Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Porto, Portugal."}, {"Identifier": [], "Affiliation": "Escola Superior de Sa\u00fade, Instituto Polit\u00e9cnico do Porto, Porto, Portugal."}], "LastName": "Baylina", "ForeName": "Pilar", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "LABMI - Laborat\u00f3rio de Biotecnologia M\u00e9dica e Industrial, PORTIC - Porto Research, Technology and Innovation Center, Porto, Portugal."}, {"Identifier": [], "Affiliation": "Metabesity Deopartment, i3S - Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Porto, Portugal."}, {"Identifier": [], "Affiliation": "Escola Superior de Sa\u00fade, Instituto Polit\u00e9cnico do Porto, Porto, Portugal."}], "LastName": "Fernandes", "ForeName": "Ruben", "Initials": "R"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Immunol", "NlmUniqueID": "101560960", "ISSNLinking": "1664-3224"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Terpenes"}, {"RegistryNumber": "19GBJ60SN5", "NameOfSubstance": "Cannabidiol"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Cannabidiol"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Drug Synergism"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects"], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Terpenes"}, {"QualifierName": ["drug effects"], "DescriptorName": "Virus Internalization"}, {"QualifierName": ["drug effects"], "DescriptorName": "Virus Replication"}], "CoiStatement": "Authors SS, AC, IL, SR and MM was employed by company EXMceuticals Portugal Lda. \u200b\u200b\u200b\u200b\u200bThe remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ford N, Vitoria M, Rangaraj A, Norris SL, Calmy A, Doherty M. Systematic Review of the Efficacy and Safety of Antiretroviral Drugs Against SARS, MERS or COVID-19: Initial Assessment. J Int AIDS Soc (2020) 23(4):e25489. doi:\u00a010.1002/jia2.25489", "ArticleIdList": ["10.1002/jia2.25489", "PMC7158851", "32293807"]}, {"Citation": "Boukhatem MN, Setzer WN. Aromatic Herbs, Medicinal Plant-Derived Essential Oils, and Phytochemical Extracts as Potential Therapies for Coronaviruses: Future Perspectives. Plants (Basel) (2020) 9(6):800. doi:\u00a010.3390/plants9060800", "ArticleIdList": ["10.3390/plants9060800", "PMC7356962", "32604842"]}, {"Citation": "Elshabrawy HA. SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries. Vaccines (Basel) (2020) 8(2):335. doi:\u00a010.3390/vaccines8020335", "ArticleIdList": ["10.3390/vaccines8020335", "PMC7350231", "32585913"]}, {"Citation": "Bergman ME, Davis B, Phillips MA. Medically Useful Plant Terpenoids: Biosynthesis, Occurrence, and Mechanism of Action. Molecules (2019) 24(21):3961. doi:\u00a010.3390/molecules24213961", "ArticleIdList": ["10.3390/molecules24213961", "PMC6864776", "31683764"]}, {"Citation": "Jaeger R, Cuny E. Terpenoids With Special Pharmacological Significance: A Review. Nat Prod Commun (2016) 11(9):1373\u201390. doi: 10.1177/1934578X1601100946", "ArticleIdList": ["10.1177/1934578X1601100946", "30807045"]}, {"Citation": "Loizzo MR, Saab AM, Tundis R, Statti GA, Menichini F, Lampronti I, et al. . Phytochemical Analysis and In Vitro Antiviral Activities of the Essential Oils of Seven Lebanon Species. Chem Biodivers (2008) 5(3):461\u201370. doi:\u00a010.1002/cbdv.200890045", "ArticleIdList": ["10.1002/cbdv.200890045", "PMC7161995", "18357554"]}, {"Citation": "Schuhmacher A, Reichling J, Schnitzler P. Virucidal Effect of Peppermint Oil on the Enveloped Viruses Herpes Simplex Virus Type 1 and Type 2 In Vitro . Phytomedicine (2003) 10(6-7):504\u201310. doi:\u00a010.1078/094471103322331467", "ArticleIdList": ["10.1078/094471103322331467", "13678235"]}, {"Citation": "Asif M, Saleem M, Saadullah M, Yaseen HS, Al Zarzour R. COVID-19 and Therapy With Essential Oils Having Antiviral, Anti-Inflammatory, and Immunomodulatory Properties. Inflammopharmacology (2020) 28(5):1153\u201361. doi:\u00a010.1007/s10787-020-00744-0. Erratum in: Inflammopharmacology. 2021 Apr;29(2):577.", "ArticleIdList": ["10.1007/s10787-020-00744-0", "PMC7427755", "32803479"]}, {"Citation": "Reichling J. Plant-Microbe Interaction and Secondary Metabolites With Antiviral, Antibacterial and Antifungal Properties. In: Wink W, editor. Functions and Biotechnology of Plant Secondary Metabolites. West Sussex, United Kingdom: Wiley-Blackwell; (2010). p. 214\u2013347. doi: 10.1002/9781119312994.apr0420", "ArticleIdList": ["10.1002/9781119312994.apr0420"]}, {"Citation": "Tahamtan A, Samieipoor Y, Nayeri FS, Rahbarimanesh AA, Izadi A, Rashidi-Nezhad A, et al. . Effects of Cannabinoid Receptor Type 2 in Respiratory Syncytial Virus Infection in Human Subjects and Mice. Virulence (2018) 9(1):217\u201330. doi:\u00a010.1080/21505594.2017.1389369", "ArticleIdList": ["10.1080/21505594.2017.1389369", "PMC5955186", "28992427"]}, {"Citation": "Sacerdote P, Martucci C, Vaccani A, Bariselli F, Panerai AE, Colombo A, et al. . The Nonpsychoactive Component of Marijuana Cannabidiol Modulates Chemotaxis and IL-10 and IL-12 Production of Murine Macrophages Both In Vivo and In Vitro . J Neuroimmunol (2005) 159(1-2):97\u2013105. doi:\u00a010.1016/j.jneuroim.2004.10.003", "ArticleIdList": ["10.1016/j.jneuroim.2004.10.003", "15652407"]}, {"Citation": "Nadjib BM. Effective Antiviral Activity of Essential Oils and Their Characteristic Terpenes Against Coronaviruses: An Update. J Pharmacol Clin Toxicol (2020) 8(1):1138."}, {"Citation": "Sandner G, Heckmann M, Weghuber J. Immunomodulatory Activities of Selected Essential Oils. Biomolecules (2020) 10(8):1139. doi:\u00a010.3390/biom10081139", "ArticleIdList": ["10.3390/biom10081139", "PMC7464830", "32756359"]}, {"Citation": "Juergens UR, Dethlefsen U, Steinkamp G, Gillissen A, Repges R, Vetter H. Anti-Inflammatory Activity of 1.8-Cineol (Eucalyptol) in Bronchial Asthma: A Double-Blind Placebo-Controlled Trial. Respir Med (2003) 97(3):250\u20136. doi:\u00a010.1053/rmed.2003.1432", "ArticleIdList": ["10.1053/rmed.2003.1432", "12645832"]}, {"Citation": "Juergens LJ, Worth H, Juergens UR. New Perspectives for Mucolytic, Anti-Inflammatory and Adjunctive Therapy With 1,8-Cineole in COPD and Asthma: Review on the New Therapeutic Approach. Adv Ther (2020) 37(5):1737\u201353. doi:\u00a010.1007/s12325-020-01279-0", "ArticleIdList": ["10.1007/s12325-020-01279-0", "PMC7467491", "32200535"]}, {"Citation": "\u00c1lvarez DM, Castillo E, Duarte LF, Arriagada J, Corrales N, Far\u00edas MA, et al. . Current Antivirals and Novel Botanical Molecules Interfering With Herpes Simplex Virus Infection. Front Microbiol (2020) 11:139. doi:\u00a010.3389/fmicb.2020.00139", "ArticleIdList": ["10.3389/fmicb.2020.00139", "PMC7026011", "32117158"]}, {"Citation": "Ramirez SH, Reichenbach NL, Fan S, Rom S, Merkel SF, Wang X, et al. . Attenuation of HIV-1 Replication in Macrophages by Cannabinoid Receptor 2 Agonists. J Leukoc Biol (2013) 93(5):801\u201310. doi:\u00a010.1189/jlb.1012523", "ArticleIdList": ["10.1189/jlb.1012523", "PMC3629438", "23463725"]}, {"Citation": "S\u00f6kmen M, Serkedjieva J, Daferera D, Gulluce M, Polissiou M, Tepe B, et al. . In Vitro Antioxidant, Antimicrobial, and Antiviral Activities of the Essential Oil and Various Extracts From Herbal Parts and Callus Cultures of Origanum Acutidens. J Agric Food Chem (2004) 52(11):3309\u201312. doi:\u00a010.1021/jf049859g", "ArticleIdList": ["10.1021/jf049859g", "15161188"]}, {"Citation": "Seidakhmetova RB, Beisenbaeva AA, Atazhanova GA, Suleimenov EM, Pak RN, Kulyyasov AT, et al. . Chemical Composition and Biological Activity of the Essential Oil From Artemisia Glabella. Pharma Chem J (2002) 36:135\u2013138.40. doi:\u00a010.1023/A:1019630327576", "ArticleIdList": ["10.1023/A:1019630327576"]}, {"Citation": "Schnitzler P, Sch\u00f6n K, Reichling J. Antiviral Activity of Australian Tea Tree Oil and Eucalyptus Oil Against Herpes Simplex Virus in Cell Culture. Pharmazie (2001) 56(4):343\u20137.", "ArticleIdList": ["11338678"]}, {"Citation": "Farag RS, Shalaby AS, El-Baroty GA, Ibrahim NA, Ali MA, Hassan EM. Chemical and Biological Evaluation of the Essential Oils of Different Melaleuca Species. Phytother Res (2004) 18(1):30\u20135. doi:\u00a010.1002/ptr.1348", "ArticleIdList": ["10.1002/ptr.1348", "14750197"]}, {"Citation": "Wen CC, Kuo YH, Jan JT, Liang PH, Wang SY, Liu HG, et al. . Specific Plant Terpenoids and Lignoids Possess Potent Antiviral Activities Against Severe Acute Respiratory Syndrome Coronavirus. J Med Chem (2007) 50(17):4087\u201395. doi:\u00a010.1021/jm070295s", "ArticleIdList": ["10.1021/jm070295s", "17663539"]}, {"Citation": "Diniz LRL, Perez-Castillo Y, Elshabrawy HA, Filho CDSMB, de Sousa DP. Bioactive Terpenes and Their Derivatives as Potential SARS-CoV-2 Proteases Inhibitors From Molecular Modeling Studies. Biomolecules (2021) 11(1):74. doi:\u00a010.3390/biom11010074", "ArticleIdList": ["10.3390/biom11010074", "PMC7825698", "33430299"]}, {"Citation": "Kintzios SE. The Biotechnology of Oregano (Origanum Sp. And Lippia Sp.). In: Kintzios SE, editor. Medicinal and Aromatic Plants-Industrial Profiles, Oregano. The Genera Origanum and Lippia, vol. 25. London: Taylor and Francis; (2002). p. 237\u201342."}, {"Citation": "Pereira MMA, Morais LC, Zeneratto NJ, Reis WSM, G\u00f3mez OC, Luiz JHH, et al. . Organic Management vs. Conventional Management Influence the Antimicrobial Activity of Essential Oils of Origanum Vulgare L. Research Soc Dev (2020) 9(11):e4239118504."}, {"Citation": "Catella C, Camero M, Lucente MS, Fracchiolla G, Sblano S, Tempesta M, et al. . Virucidal and Antiviral Effects of Thymus Vulgaris Essential Oil on Feline Coronavirus. Res Vet Sci (2021) 137:44\u20137. doi:\u00a010.1016/j.rvsc.2021.04.024", "ArticleIdList": ["10.1016/j.rvsc.2021.04.024", "PMC8061179", "33932822"]}, {"Citation": "Russo EB. Taming THC: Potential Cannabis Synergy and Phytocannabinoid-Terpenoid Entourage Effects. Br J Pharmacol (2011) 163(7):1344\u201364. doi:\u00a010.1111/j.1476-5381.2011.01238", "ArticleIdList": ["10.1111/j.1476-5381.2011.01238", "PMC3165946", "21749363"]}, {"Citation": "Mediavilla V, Steinemann S. Essential Oil of Cannabis Sativa L. Strains. J Int Hemp Assoc (1997) 4:80\u20132."}, {"Citation": "Elsohly MA, Slade D. Chemical Constituents of Marijuana: The Complex Mixture of Natural Cannabinoids. Life Sci (2005) 78(5):539\u201348. doi:\u00a010.1016/j.lfs.2005.09.011", "ArticleIdList": ["10.1016/j.lfs.2005.09.011", "16199061"]}, {"Citation": "Sommano SR, Chittasupho C, Ruksiriwanich W, Jantrawut P. The Cannabis Terpenes. Molecules (2020) 25(24):5792. doi:\u00a010.3390/molecules25245792", "ArticleIdList": ["10.3390/molecules25245792", "PMC7763918", "33302574"]}, {"Citation": "Fasinu PS, Phillips S, ElSohly MA, Walker LA. Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents. Pharmacotherapy (2016) 36(7):781\u201396. doi:\u00a010.1002/phar.1780", "ArticleIdList": ["10.1002/phar.1780", "27285147"]}, {"Citation": "Bridgeman MB, Abazia DT. Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting. P T (2017) 42(3):180\u20138.", "ArticleIdList": ["PMC5312634", "28250701"]}, {"Citation": "Burstein S. Cannabidiol (CBD) and Its Analogs: A Review of Their Effects on Inflammation. Bioorg Med Chem (2015) 23(7):1377\u201385. doi:\u00a010.1016/j.bmc.2015.01.059", "ArticleIdList": ["10.1016/j.bmc.2015.01.059", "25703248"]}, {"Citation": "Amin MR, Ali DW. Pharmacology of Medical Cannabis. Adv Exp Med Biol (2019) 1162:151\u201365. doi:\u00a010.1007/978-3-030-21737-2_8", "ArticleIdList": ["10.1007/978-3-030-21737-2_8", "31332738"]}, {"Citation": "De Petrocellis L, Ligresti A, Moriello AS, Allar\u00e0 M, Bisogno T, Petrosino S. Effects of Cannabinoids and Cannabinoid-Enriched Cannabis Extracts on TRP Channels and Endocannabinoid Metabolic Enzymes. Br J Pharmacol (2011) 163:1479\u201394. doi:\u00a010.1111/j.1476-5381.2010.01166.x", "ArticleIdList": ["10.1111/j.1476-5381.2010.01166.x", "PMC3165957", "21175579"]}, {"Citation": "Robaina Cabrera CL, Keir-Rudman S, Horniman N, Clarkson N, Page C. The Anti-Inflammatory Effects of Cannabidiol and Cannabigerol Alone, and in Combination. Pulm Pharmacol Ther (2021) 69:102047. doi:\u00a010.1016/j.pupt.2021.102047", "ArticleIdList": ["10.1016/j.pupt.2021.102047", "34082108"]}, {"Citation": "An D, Peigneur S, Hendrickx LA, Tytgat J. Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products. Int J Mol Sci (2020) 21(14):5064. doi:\u00a010.3390/ijms21145064", "ArticleIdList": ["10.3390/ijms21145064", "PMC7404216", "32709050"]}, {"Citation": "Zou S, Kumar U. Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System. Int J Mol Sci (2018) 19(3):833. doi:\u00a010.3390/ijms19030833", "ArticleIdList": ["10.3390/ijms19030833", "PMC5877694", "29533978"]}, {"Citation": "Jordan CJ, Xi ZX. Progress in Brain Cannabinoid CB2 Receptor Research: From Genes to Behavior. Neurosci Biobehav Rev (2019) 98:208\u201320. doi:\u00a010.1016/j.neubiorev.2018.12.026", "ArticleIdList": ["10.1016/j.neubiorev.2018.12.026", "PMC6401261", "30611802"]}, {"Citation": "Gui H, Sun Y, Luo ZM, Su DF, Dai SM, Liu X. Cannabinoid Receptor 2 Protects Against Acute Experimental Sepsis in Mice. Mediators Inflamm (2013) 2013:741303. doi:\u00a010.1155/2013/741303", "ArticleIdList": ["10.1155/2013/741303", "PMC3679685", "23781122"]}, {"Citation": "Rossi F, Tortora C, Argenziano M, Di Paola A, Punzo F. Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection? Int J Mol Sci (2020) 21(11):3809. doi:\u00a010.3390/ijms21113809", "ArticleIdList": ["10.3390/ijms21113809", "PMC7312493", "32471272"]}, {"Citation": "Costiniuk CT, Saneei Z, Routy JP, Margolese S, Mandarino E, Singer J, et al. . Oral Cannabinoids in People Living With HIV on Effective Antiretroviral Therapy: CTN PT028-Study Protocol for a Pilot Randomised Trial to Assess Safety, Tolerability and Effect on Immune Activation. BMJ Open (2019) 9(1):e024793. doi:\u00a010.1136/bmjopen-2018-024793", "ArticleIdList": ["10.1136/bmjopen-2018-024793", "PMC6340429", "30659041"]}, {"Citation": "Karmaus PW, Chen W, Crawford R, Kaplan BL, Kaminski NE. \u03949-Tetrahydrocannabinol Impairs the Inflammatory Response to Influenza Infection: Role of Antigen-Presenting Cells and the Cannabinoid Receptors 1 and 2. Toxicol Sci (2013) 131(2):419\u201333. doi:\u00a010.1093/toxsci/kfs315", "ArticleIdList": ["10.1093/toxsci/kfs315", "PMC3551428", "23152191"]}, {"Citation": "Buchweitz JP, Karmaus PW, Williams KJ, Harkema JR, Kaminski NE. Targeted Deletion of Cannabinoid Receptors CB1 and CB2 Produced Enhanced Inflammatory Responses to Influenza A/PR/8/34 in the Absence and Presence of Delta9-Tetrahydrocannabinol. J Leukoc Biol (2008) 83(3):785\u201396. doi:\u00a010.1189/jlb.0907618", "ArticleIdList": ["10.1189/jlb.0907618", "18073275"]}, {"Citation": "Brown JD. Cannabidiol as Prophylaxis for SARS-CoV-2 and COVID-19? Unfounded Claims Versus Potential Risks of Medications During the Pandemic. Res Soc Adm Pharm (2021) 17(1):2053. doi:\u00a010.1016/j.sapharm.2020.03.020", "ArticleIdList": ["10.1016/j.sapharm.2020.03.020", "PMC7269703", "32273254"]}, {"Citation": "Onay A, Erta\u015f A, S\u00fczerer V, Yener \u0130, Yilmaz MA, Ayaz-Tilkat E, et al. . Cannabinoids for SARS-CoV-2 and Is There Evidence of Their Therapeutic Efficacy? Turk J Biol (2021) 45(4):570\u201387. doi:\u00a010.3906/biy-2105-73", "ArticleIdList": ["10.3906/biy-2105-73", "PMC8573844", "34803455"]}, {"Citation": "Paland N, Pechkovsky A, Aswad M, Hamza H, Popov T, Shahar E, et al. . The Immunopathology of COVID-19 and the Cannabis Paradigm. Front Immunol (2021) 12:631233. doi:\u00a010.3389/fimmu.2021.631233", "ArticleIdList": ["10.3389/fimmu.2021.631233", "PMC7907157", "33643316"]}, {"Citation": "El Biali M, Broers B, Besson M, Demeules J. Cannabinoids and COVID-19. Med Cannabis Cannabinoids (2020) 3(2):111\u20135. doi:\u00a010.1159/000510799", "ArticleIdList": ["10.1159/000510799", "PMC7490504", "34671712"]}, {"Citation": "Wang B, Kovalchuk A, Li D, Rodriguez-Juarez R, Ilnytskyy Y, Kovalchuk I, et al. . In Search of Preventive Strategies: Novel High-CBD Cannabis Sativa Extracts Modulate ACE2 Expression in COVID-19 Gateway Tissues. Aging (Albany NY) (2020) 12(22):22425\u201344. doi:\u00a010.18632/aging.202225", "ArticleIdList": ["10.18632/aging.202225", "PMC7746344", "33221759"]}, {"Citation": "Anil SM, Shalev N, Vinayaka AC, Nadarajan S, Namdar D, Belausov E, et al. . Cannabis Compounds Exhibit Anti-Inflammatory Activity In Vitro in COVID-19-Related Inflammation in Lung Epithelial Cells and Pro-Inflammatory Activity in Macrophages. Sci Rep (2021) 11(1):1462. doi:\u00a010.1038/s41598-021-81049-2", "ArticleIdList": ["10.1038/s41598-021-81049-2", "PMC7809280", "33446817"]}, {"Citation": "Chatow L, Nudel A, Nesher I, Hayo Hemo D, Rozenberg P, Voropaev H, et al. . In Vitro Evaluation of the Activity of Terpenes and Cannabidiol Against Human Coronavirus E229. Life (Basel) (2021) 11(4):290. doi:\u00a010.3390/life11040290", "ArticleIdList": ["10.3390/life11040290", "PMC8065867", "33805385"]}, {"Citation": "Gallily R, Yekhtin Z, Hanu\u0161 LO. The Anti-Inflammatory Properties of Terpenoids From Cannabis . Cannabis Cannabinoid Res (2018) 3(1):282\u201390. doi:\u00a010.1089/can.2018.0014", "ArticleIdList": ["10.1089/can.2018.0014", "PMC6308289", "30596146"]}, {"Citation": "Baron EP. Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science. Headache (2018) 58(7):1139\u201386. doi:\u00a010.1111/head.13345", "ArticleIdList": ["10.1111/head.13345", "30152161"]}, {"Citation": "Maayah ZH, Takahara S, Ferdaoussi M, Dyck JRB. The Molecular Mechanisms That Underpin the Biological Benefits of Full-Spectrum Cannabis Extract in the Treatment of Neuropathic Pain and Inflammation. Biochim Biophys Acta Mol Basis Dis (2020) 1866(7):165771. doi:\u00a010.1016/j.bbadis.2020.165771", "ArticleIdList": ["10.1016/j.bbadis.2020.165771", "32201189"]}, {"Citation": "Namdar D, Voet H, Ajjampura V, Nadarajan S, Mayzlish-Gati E, Mazuz M, et al. . Terpenoids and Phytocannabinoids Co-Produced in Cannabis Sativa Strains Show Specific Interaction for Cell Cytotoxic Activity. Molecules (2019) 24(17):3031. doi:\u00a010.3390/molecules24173031", "ArticleIdList": ["10.3390/molecules24173031", "PMC6749504", "31438532"]}, {"Citation": "Bojkova D, Klann K, Koch B, Widera M, Krause D, Ciesek S, et al. . Proteomics of SARS-CoV-2-Infected Host Cells Reveals Therapy Targets. Nature (2020) 583(7816):469\u201372. doi:\u00a010.1038/s41586-020-2332-7", "ArticleIdList": ["10.1038/s41586-020-2332-7", "32408336"]}, {"Citation": "Rosa RB, Dantas WM, do Nascimento JCF, da Silva MV, de Oliveira RN, Pena LJ. In Vitro and In Vivo Models for Studying SARS-CoV-2, the Etiological Agent Responsible for COVID-19 Pandemic. Viruses (2021) 13(3):379. doi:\u00a010.3390/v13030379", "ArticleIdList": ["10.3390/v13030379", "PMC7997194", "33673614"]}, {"Citation": "Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for Gastrointestinal Infection of SARS-CoV-2. Gastroenterology (2020) 158(6):1831\u20131833.e3. doi:\u00a010.1053/j.gastro.2020.02.055", "ArticleIdList": ["10.1053/j.gastro.2020.02.055", "PMC7130181", "32142773"]}, {"Citation": "Lee S, Yoon GY, Myoung J, Kim SJ, Ahn DG. Robust and Persistent SARS-CoV-2 Infection in the Human Intestinal Brush Border Expressing Cells. Emerg Microbes Infect (2020) 9(1):2169\u201379. doi:\u00a010.1080/22221751.2020.1827985", "ArticleIdList": ["10.1080/22221751.2020.1827985", "PMC7580600", "32969768"]}, {"Citation": "Kellum JA, van Till JWO, Mulligan G. Targeting Acute Kidney Injury in COVID-19. Nephrol Dial Transplant (2020) 35(10):1652\u201362. doi:\u00a010.1093/ndt/gfaa231", "ArticleIdList": ["10.1093/ndt/gfaa231", "PMC7665651", "33022712"]}, {"Citation": "Liakopoulos V, Roumeliotis S, Papachristou S, Papanas N. COVID-19 and the Kidney: Time to Take a Closer Look. Int Urol Nephrol (2021), 1\u20135. doi:\u00a010.1007/s11255-021-02976-7", "ArticleIdList": ["10.1007/s11255-021-02976-7", "PMC8358250", "34383205"]}, {"Citation": "Novak N, Peng W, Naegeli MC, Galvan C, Kolm-Djamei I, Br\u00fcggen C, et al. . SARS-CoV-2, COVID-19, Skin and Immunology - What Do We Know So Far? Allergy (2021) 76(3):698\u2013713. doi:\u00a010.1111/all.14498", "ArticleIdList": ["10.1111/all.14498", "PMC7404682", "32658359"]}, {"Citation": "Recalcati S. Cutaneous Manifestations in COVID-19: A First Perspective. J\u00a0Eur Acad Dermatol Venereol (2020) 34(5):e212\u20133. doi:\u00a010.1111/jdv.16387", "ArticleIdList": ["10.1111/jdv.16387", "32215952"]}, {"Citation": "Wollina U, Karada\u011f AS, Rowland-Payne C, Chiriac A, Lotti T. Cutaneous Signs in COVID-19 Patients: A Review. Dermatol Ther (2020) 33(5):e13549. doi:\u00a010.1111/dth.13549", "ArticleIdList": ["10.1111/dth.13549", "PMC7273098", "32390279"]}, {"Citation": "Matar S, Oul\u00e8s B, Sohier P, Chosidow O, Beylot-Barry M, Dupin N, et al. . Cutaneous Manifestations in SARS-CoV-2 Infection (COVID19): A French Experience and a Systematic Review of the Literature. J Eur Acad Dermatol Venereol (2020) 34(11):e686\u20139. doi:\u00a010.1111/jdv.16775", "ArticleIdList": ["10.1111/jdv.16775", "PMC7361331", "32589293"]}, {"Citation": "Gisondi P, PIaserico S, Bordin C, Alaibac M, Girolomoni G, Naldi L. Cutaneous Manifestations of SARS-CoV-2 Infection: A Clinical Update. J\u00a0Eur Acad Dermatol Venereol (2020) 34(11):2499\u2013504. doi:\u00a010.1111/jdv.16774", "ArticleIdList": ["10.1111/jdv.16774", "PMC7362144", "32585074"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "12", "Day": "22"}, {"Year": "2022", "Month": "1", "Day": "21"}, {"Year": "2022", "Month": "3", "Day": "4", "Hour": "5", "Minute": "40"}, {"Year": "2022", "Month": "3", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "15"}], "PublicationStatus": "epublish", "ArticleIdList": ["35242142", "PMC8886108", "10.3389/fimmu.2022.841459"]}}], "PubmedBookArticle": []}